Unió Europea - búlgar - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - Множествена миелома - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Unió Europea - búlgar - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - Имунни серуми и имуноглобулини - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.

Unió Europea - búlgar - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - Множествена миелома - Антинеопластични средства - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Unió Europea - búlgar - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - Новообразувания На Простатата, Кастраци-Упорит - Антинеопластични средства - treatment of adult patients with prostate cancer.

Unió Europea - búlgar - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Антинеопластични средства - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Unió Europea - búlgar - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - Множествена миелома - Антинеопластични средства - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Unió Europea - búlgar - EMA (European Medicines Agency)

teva gmbh - fremanezumab - Мигренозни разстройства - calcitonin gene-related peptide (cgrp) antagonists - ajovy е показан за профилактика на мигрена при възрастни, които имат най-малко 4 дни мигрена на месец.

Bulgària - búlgar - БАБХ (Българска агенция по безопасност на храните)

virbac - Празиквантел, ivermectin - таблетки за дъвчене - 150 mg/таблетка, 20 mg/таблетка - коне